Sotera Health Co. (SHC) Tops Q4 EPS by 3c

Sotera Health Co. (NASDAQ: SHC) reported Q4 EPS of $0.25, $0.03 better than the analyst estimate of $0.22. Revenue for the quarter came in at $252 million versus the consensus estimate of $247.46 million.

GUIDANCE:

Sotera Health Co. sees FY2023 EPS of $0.78-$0.86, versus the consensus of $1.01. Sotera Health Co. sees FY2023 revenue of $1.06-1.09 billion, versus the consensus of $1.08 billion.

For earnings history and earnings-related data on Sotera Health Co. (SHC) click here.

You May Also Be Interested In

• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
• Accenture tumbles 16% on guidance cut; announces Dragos, runZero, NetRise deals
• Air France-KLM (AF:FP) (AFLYY) PT Raised to EUR13.50 at UBS